• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[治疗所需人数及其各自的置信区间:评估与医学干预相关的临床意义和不确定性的有用工具]

[Numbers needed for treatment and their respective confidence intervals: useful tools to assess clinical significance and uncertainty associated with medical interventions].

作者信息

Sampaio C, Ferreira J, Costa J

机构信息

Instituto de Farmacologia e Terapêutica Geral, Faculdade de Medicina de Lisboa.

出版信息

Rev Port Cardiol. 2000 Dec;19(12):1303-8.

PMID:11220124
Abstract

This is a narrative review of a concept--number needed to treat (NNT). The proprieties of NNTs are described. Furthermore NNTs as important tools for medical decision are discussed. In particular, conditions that make calculus and the interpretation of NNTs somewhat more complex are commented. Namely, we consider situations where the results are not primarily binary or are expressed as "time to event" or come from a meta-analysis. The inconsistencies that might occur when NNTs are calculated from meta-analysis are discussed in some detail. Definitions for parameters derived from NNTs, as numbers needed to harm (NNH), unqualified success (NNTUS) and unmitigated failure (NNHUF) are given. Finally the usefulness of NNTs and absolute risk reductions to communicate risk to individual patients are considered. It is concluded that despite NNTs being powerful tools for medical decision, in the case of communicating risks to the individual patient absolute risks might be preferable.

摘要

这是一篇关于“治疗所需人数(NNT)”这一概念的叙述性综述。文中描述了NNT的特性。此外,还讨论了NNT作为医疗决策重要工具的情况。特别评论了使NNT的计算和解释变得更为复杂的一些情况。具体而言,我们考虑了结果并非主要为二元性、以“事件发生时间”表示或来自荟萃分析的情形。文中较为详细地讨论了从荟萃分析计算NNT时可能出现的不一致性。给出了从NNT衍生出的参数定义,如伤害所需人数(NNH)、无附加条件成功所需人数(NNTUS)和完全失败所需人数(NNHUF)。最后,探讨了NNT和绝对风险降低率在向个体患者传达风险方面的作用。得出的结论是,尽管NNT是医疗决策的有力工具,但在向个体患者传达风险时,绝对风险可能更可取。

相似文献

1
[Numbers needed for treatment and their respective confidence intervals: useful tools to assess clinical significance and uncertainty associated with medical interventions].[治疗所需人数及其各自的置信区间:评估与医学干预相关的临床意义和不确定性的有用工具]
Rev Port Cardiol. 2000 Dec;19(12):1303-8.
2
Reporting risks and benefits of therapy by use of the concepts of unqualified success and unmitigated failure: applications to highly cited trials in cardiovascular medicine.
Circulation. 1999 Jan 26;99(3):377-83. doi: 10.1161/01.cir.99.3.377.
3
Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials.需治疗人数和需伤害人数并非报告和评估随机临床试验结果的最佳方式。
Br J Haematol. 2009 Jun;146(1):27-30. doi: 10.1111/j.1365-2141.2009.07707.x. Epub 2009 Apr 27.
4
Communicating the benefits and harms of treatments.传达治疗的益处与危害。
Arch Dis Child. 2008 Aug;93(8):710-3. doi: 10.1136/adc.2008.137083. Epub 2008 May 2.
5
How effective is that treatment? The number needed to treat.那种治疗方法的效果如何?需治疗人数。
Tex Dent J. 2011 Feb;128(2):211-9.
6
Evidence-based dermatology: number needed to treat and its relation to other risk measures.循证皮肤病学:治疗所需人数及其与其他风险指标的关系。
J Am Acad Dermatol. 2007 Apr;56(4):664-71. doi: 10.1016/j.jaad.2006.08.024. Epub 2006 Oct 27.
7
The number needed to harm: is it too optimistic?伤害所需人数:这是否过于乐观?
Can J Cardiol. 2003 Dec;19(13):1490-2.
8
[The number needed to treat (NNT)].[需治疗人数(NNT)]
Rev Med Brux. 2011 Sep-Oct;32(5):453-8.
9
Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke.纳入临床结局全范围效应的需治疗人数估计:新的推导方法及其在急性卒中溶栓治疗中的应用
Arch Neurol. 2004 Jul;61(7):1066-70. doi: 10.1001/archneur.61.7.1066.
10
[Number needed to treat (NNT)-- misleading, misunderstood, misused?].[需治疗人数(NNT)——误导、误解、误用?]
Tidsskr Nor Laegeforen. 2004 Aug 12;124(15):1926-9.